期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Identification of African swine fever virus MGF505-2R as a potent inhibitor of innate immunity in vitro
1
作者 Huaguo Huang Wen Dang +6 位作者 zhengwang shi Mingyang Ding Fan Xu Tao Li Tao Feng Haixue Zheng Shuqi Xiao 《Virologica Sinica》 SCIE CAS CSCD 2023年第1期84-95,共12页
African swine fever(ASF)is etiologically an acute,highly contagious and hemorrhagic disease caused by African swine fever virus(ASFV).Due to its genetic variation and phenotypic diversity,until now,no efficient commer... African swine fever(ASF)is etiologically an acute,highly contagious and hemorrhagic disease caused by African swine fever virus(ASFV).Due to its genetic variation and phenotypic diversity,until now,no efficient commercial vaccines or therapeutic options are available.The ASFV genome contains a conserved middle region and two flexible ends that code for five multigene families(MGFs),while the biological functions of the MGFs are not fully characterized.Here,ASFV MGF505-2R-deficient mutant ASFV-Δ2R was constructed based on a highly virulent genotype II field isolate ASFV CN/GS/2018 currently circulating in China.Transcriptomic profiling demonstrated that ASFV-Δ2R was capable of inducing a larger number of differentially expressed genes(DEGs)compared with ASFV CN/GS/2018.Hierarchical clustering of up-regulated DEGs revealed that ASFV-Δ2R induced the most dramatic expression of interferon-related genes and inflammatory and innate immune genes,as further validated by RT-qPCR.The GO and KEGG pathway analysis identified significantly enriched pathways involved in pathogen recognition and innate antiviral immunity.Conversely,pharmacological activation of those antiviral immune responses by exogenous cytokines,including type I/II IFNs,TNF-αand IL-1β,exerted combinatory effects and synergized in antiviral capacity against ASFV replication.Collectively,MGF505-2R is a newly identified inhibitor of innate immunity potentially implicated in immune evasion. 展开更多
关键词 African swine fever virus(ASFV) Multigene families(MGFs) MGF505-2R Differentially expressed genes(DEGs)
原文传递
A型塞内卡病毒的病毒样颗粒的制备及其免疫原性分析 被引量:2
2
作者 伍春平 茹毅 +8 位作者 田宏 马坤 郝荣增 李亚军 罗俊聪 石正旺 刘华南 左志 郑海学 《生物工程学报》 CAS CSCD 北大核心 2021年第9期3211-3220,共10页
为了研制A型塞内卡病毒(Senecavirus A,SVA)的病毒样颗粒(Virus-like particles,VLPs)疫苗,以SVA田间流行毒株CH-FJ-2017结构蛋白基因序列为研究对象,构建了能够同时表达SVA的3种结构蛋白VP0、VP1和VP3的单个原核重组表达质粒pET28a-SVA... 为了研制A型塞内卡病毒(Senecavirus A,SVA)的病毒样颗粒(Virus-like particles,VLPs)疫苗,以SVA田间流行毒株CH-FJ-2017结构蛋白基因序列为研究对象,构建了能够同时表达SVA的3种结构蛋白VP0、VP1和VP3的单个原核重组表达质粒pET28a-SVA-VP031。通过大肠杆菌Escherichia coli表达、亲和层析纯化和体外自组装,获得SVA VLPs。透射电子显微镜鉴定显示,SVA的3种结构蛋白在体外能够自组装成直径约25–30 nm的VLPs,并且动物免疫试验结果表明,该VLPs能够有效刺激豚鼠产生高水平的抗原特异性中和抗体。上述研究结果为SVA VLPs疫苗的研制奠定了基础。 展开更多
关键词 A型塞内卡病毒 病毒样颗粒 结构蛋白 免疫原性
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部